Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade ...

U.S. Senator Tammy Baldwin (D-WI) joined a group of her colleagues in introducing the Capping Prescription Costs Act, ...

If you enrolled in an optional Medicare Part D plan in 2024 or before, at some point you probably faced a coverage gap called the “donut hole,” a temporary limit on what your Part D plan will pay for ...

Determining the various costs of Medicare can be confusing. There are annual deductibles, monthly premiums and doctor visit ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

On Wednesday, Senator Kristen Gillibrand announced legislation to help reduce prescription drug costs. According to the ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its ...